ESPB vs.Combination of ESPB and Superficial PIPB in Cardiac Surgery

Not Applicable

Completed

• Conditions: Anesthesia; Acute Pain; Analgesia; Patient Controlled Analgesia
• Interventions: Procedure: Bilateral ultrasound-guided ESPB and superficial PIPB; Procedure: Bilateral ultrasound-guided ESPB

• Registration Number: NCT05191953
• Lead Sponsor: Ondokuz Mayıs University

Brief Summary

Cardiac surgery is associated with significant postoperative pain. Pain control is an essential part of enhanced recovery protocols. The aim of this study is to evaluate and compare the analgesic efficacies of erector spinae plane block (ESPB) and the combination of ESPB and superficial parasternal intercostal plane block (PIPB) in patients undergoing elective cardiac surgery.

Detailed Description

Many regional techniques have been used to manage postoperative pain in cardiac surgery, including thoracic epidural anesthesia, paravertebral, intercostal nerve block, intrathecal spinal morphine, and local infiltration. Increased risk of epidural/spinal hematoma secondary to systemic heparinization, potential hemodynamic instability, technical difficulties and complications such as pneumothorax are potential serious drawbacks. Due to the aforementioned reasons, anesthetists are understandably preferring ultrasound (US) guided interfascial plane blocks, which are generally thought to provide safer and more effective analgesia in cardiac surgery.

This study aims to evaluate and compare the effects of ESPB versus ESPB plus Superficial PIPB on pain scores and opioid consumption in patients undergoing elective cardiac surgery.

Patients will be divided into two groups:

Group ESPB:

In this group, patients will be administered bilateral ESPB (total of 40 ml, %0.25 bupivacaine) in addition to IV morphine patient-controlled analgesia (PCA) for the first 24 postoperative hours.

Group ESPB+Superficial PIPB:

In this group, patients will be administered Bilateral ESPB (total of 40 ml, %0.25 bupivacaine) and bilateral Superficial PIPB (total of 20 ml, %0.25 bupivacaine). In addition, IV morphine PCA will be administered for the first 24 postoperative hours.

Study Timeline

• Study First Submitted: 2021-12-29
• Study First Submitted QC: 2022-01-13
• Study First Posted: 2022-01-14
• Study Start: 2022-01-26
• Primary Completion: 2022-05-17
• Status Verified: 2022-06
• Study Completion: 2022-06-25
• Last Update Submitted: 2022-06-25
• Last Update Posted: 2022-06-28

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 48

Inclusion Criteria

• American Society of Anesthesiologists (ASA) 2-3 patients between the ages of 18-80 who are scheduled for elective cardiac surgery (coronary artery bypass graft surgery +/- valve replacement or isolated valve surgery)
• BMI <35 kg / m2

Exclusion Criteria

• Emergent surgeries, redo cases, minimally invasive procedures
• Patients who do not want to participate
• Patients with cognitive dysfunction (patients who are not able to evaluate the verbal numerical pain scale)
• Hypersensitivity or history of allergies to local anesthetics
• Major liver or kidney dysfunction or other pre-existing major organ dysfunction
• Left ventricular ejection fraction <30
• Individuals with mental health disorders (for example bipolar disorder or depression)
• Pregnancy or breastfeeding
• Presence of hematological disease
• Patients with alcohol-drug addiction

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Group ESPB+Superficial PIPB	Bilateral ultrasound-guided ESPB and superficial PIPB	A bilateral ESPB (40 ml, %0.25 bupivacaine, totally) and a bilateral superficial PIPB (20 ml, %0.25 bupivacaine, totally) + IV morphine-PCA
Group ESPB	Bilateral ultrasound-guided ESPB	A bilateral ESPB (40 ml, %0.25 bupivacaine, totally) + IV morphine-PCA

Primary Outcome Measures

Name	Time	Method
Morphine consumption in the first 24 hours after surgery	Postoperative day 1	Morphine consumption in the first 24 hours will be measured. Patients will be able to request opioids via a PCA device when their NRS score ≥4.

Secondary Outcome Measures

Name	Time	Method
Postoperative pain scores	Postoperative day 1	Pain at rest and while coughing will be assessed by numerical rating scale (NRS) scores at 0, 3, 6, 12, 18, and 24 hours after extubation. The NRS is an 11-point numeric scale that ranges from 0 to 10. The NRS is an 11-point scale consisting of integers from 0 to 10: 0 indicates "no pain" and 10 indicates "the worst pain ever possible." One day before the surgery, all patients will be informed about NRS and instructed on how to use a patient-controlled analgesia device.
Time to extubation	Postoperative day 1	After the operation, the time until the patient is extubated will be recorded.
The number of patient requiring rescue analgesic	Postoperative Day 1	The number of patients who required rescue analgesics will be recorded at 0, 3, 6, 12, 18, and 24 hours after extubation.
The incidences of post-operative nausea and vomiting (PONV)	Postoperative Day 1	The severity of postoperative nausea and vomiting (PONV) will be assessed using a descriptive verbal rating scale at 0, 3, 6, 12, 18, and 24 hours after extubation. If a score of 3 or more ondansetron 4 mg IV will be administered and will repeat after 8 hours if required.The PONV scale is 0 = no nausea; 1 = slight nausea; 2 = moderate nausea; 3 = vomiting once; and 4 = vomiting more than once.
Patient satisfaction as measured by the Revised American Pain Society Patient Outcome Questionnaire	Postoperative Day 1	The Revised American Pain Society Patient Outcome Questionnaire will be used to assess satisfaction with pain expectation counseling (APS-POQ-R). The APS-POQ-R is designed for use in adult hospital pain management quality improvement activities, and it assesses six aspects of care: (1) pain severity and relief; (2) impact of pain on activity, sleep, and negative emotions; (3) side effects of treatment; (4) usefulness of pain treatment information; (5) ability to participate in pain treatment decisions; and (6) use of nonpharmacological strategies.; Participants will rate themselves on a scale of 0 to 10. They were either severely dissatisfied or extremely satisfied, with a score of 0 indicating extreme dissatisfaction and 10 indicating extreme satisfaction.; APS-POQ-R Turkish Version will be used for assessment.
The number of patients with complications	Postoperative 7 days on an average	The number of patients have any complications -directly related to the block or the drug used in the block- will be recorded.

Trial Locations

Locations (1)

Ondokuz Mayis University; 🇹🇷 Samsun, Atakum, Turkey